Menu Close

Congrats to Dr. Tasdemir and colleagues on their new BioRxiv pre-print!

Congratulations to Nilgun Tasdemir on her new publication!

Proteomic and Transcriptomic Profiling Identifies Mediators of Anchorage-Independent Growth and Roles of Inhibitor of Differentiation Proteins in Invasive Lobular Breast Cancer – biorxiv.org

Abstract. BACKGROUND: Invasive lobular carcinoma (ILC) is a histological subtype of breast cancer with distinct molecular and clinical features from the more common subtype invasive lobular carcinoma (IDC).www.biorxiv.org

Dr. Adrian Lee interviewed on the “Do-Goodery Podcast: The Cancer Episode”!

Dr. Adrian Lee was recently interviewed for the “Do-Goodery Podcast: The Cancer Episode” to, as described by their website, “discuss what a jerk Cancer is. We Take Astro 101, learn about new weapons in the fight against Cancer, and how to support those who’ve received a Cancer diagnosis.”

Listen here:

 

Dr. Oesterreich discusses ILC at NWMBCC in Seattle

Steffi meets with members of LBCA advocacy group (https://lobularbreastcancer.org/), and discusses progress and challenges for ILC research at the Northwest Metastatic Breast Cancer Conference (NWMBCC).

The presentation was live streamed, and can be seen here: https://www.facebook.com/lobularbreastcanceralliance/videos/553742191751845/.

Of note, Leigh Pate, founder of LBCA, receives the Beth Caldwell Breakthrough Leadership award.